New meningitis vaccine for toddlers shows promise in major trial
NCT ID NCT07505836
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new vaccine to protect young children (12-23 months old) against four types of meningococcal bacteria that can cause meningitis. About 1,040 toddlers will receive either the new vaccine or an existing one to see if the new vaccine is as safe and effective. The goal is to help prevent this serious infection in more children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDEMIC MENINGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive study tracks meningitis trends in 10,000 kids
- New meningitis vaccine for kids shows promise in large trial
- New meningitis vaccine trial aims to shield babies from deadly infection
- New meningitis vaccine trial aims to protect babies
- New vaccine study aims to shield toddlers from deadly meningitis
- One shot to rule them all? new combo vaccine trial for kids begins